↓ Skip to main content

Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo

Overview of attention for article published in Molecular Cancer, June 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
69 Dimensions

Readers on

mendeley
118 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo
Published in
Molecular Cancer, June 2010
DOI 10.1186/1476-4598-9-139
Pubmed ID
Authors

Yi-Fan Hsu, Daniel Ajona, Leticia Corrales, Jose M Lopez-Picazo, Alfonso Gurpide, Luis M Montuenga, Ruben Pio

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
United States 1 <1%
Netherlands 1 <1%
Unknown 115 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 33 28%
Student > Ph. D. Student 19 16%
Student > Bachelor 15 13%
Student > Master 11 9%
Other 7 6%
Other 10 8%
Unknown 23 19%
Readers by discipline Count As %
Agricultural and Biological Sciences 25 21%
Biochemistry, Genetics and Molecular Biology 25 21%
Medicine and Dentistry 20 17%
Immunology and Microbiology 11 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 6 5%
Unknown 27 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2024.
All research outputs
#5,372,093
of 25,177,382 outputs
Outputs from Molecular Cancer
#437
of 1,894 outputs
Outputs of similar age
#21,872
of 102,803 outputs
Outputs of similar age from Molecular Cancer
#7
of 26 outputs
Altmetric has tracked 25,177,382 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,894 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 102,803 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.